Trinity Biotech's Uni-Gold
This article was originally published in The Gray Sheet
Executive Summary
Rapid HIV test investigational device exemption allows use in cases of needlestick injury and high-risk pregnancy, to provide data for a future PMA supplement. A Feb. 5 PMA is pending for broader use of the test, which provides results in under 15 minutes. No rapid HIV test is currently marketed in the U.S. following temporary withdrawal of Abbott's SUDS HIV-1 rapid test due to quality control issues (1"The Gray Sheet" Oct. 23, 2000, p. 24)
You may also be interested in...
Abbott Investigating SUDS HIV-1 Test Production Problems, Exhausts Supply
Production of Abbott Laboratories' single-use diagnostic system (SUDS) HIV-1 rapid test could resume within the next 30 days, the firm says following a halt in production due to a failure to meet certain panel and negative control specifications.
Cosmetic And Personal Care Trademark Review: 9 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.